Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
Kosuke Okazaki, Manabu Makinodan, Kazuhiko Yamamuro, Tomoyo Takata, Toshifumi Kishimoto Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, JapanObjective: Methamphetamine (MA) use has recently been associated with high levels of psychiatric hospitalization and serious s...
Enregistré dans:
Auteurs principaux: | Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef891a952396438a8f6f9cb5c5412e2b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Age of Onset and Its Related Factors in Cocaine or Methamphetamine Use in Adults from the United States: Results from NHANES 2005–2018
par: Alexandre Arthur Guerin, et autres
Publié: (2021) -
Effects of Buprenorphine on the Memory and Learning Deficit Induced by Methamphetamine Administration in Male Rats
par: Farshid Etaee, et autres
Publié: (2021) -
A Zebrafish Model of Neurotoxicity by Binge-Like Methamphetamine Exposure
par: Juliette Bedrossiantz, et autres
Publié: (2021) -
FREQUENCY OF PSYCHOTIC SYMPTOMS IN METHAMPHETAMINE USERS
par: Ihsan Ullah Kasi, et autres
Publié: (2020) -
Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence
par: Huan Liu, et autres
Publié: (2021)